Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

TRIO PETROLEUM ANNOUNCES LLOYDMINSTER ACQUISITION WITH CUMMINGS MULTILATERAL OIL WELL AND WORKOVER PRODUCTION GROWTH OPPORTUNITY

TRIO PETROLEUM ANNOUNCES LLOYDMINSTER ACQUISITION WITH CUMMINGS MULTILATERAL OIL WELL AND WORKOVER PRODUCTION GROWTH OPPORTUNITY

Trio Petroleum Corp announced that its Canadian subsidiary acquired 24 oil wells from Marlin Resources in Saskatchewan's Lloydminster region, including 4 producing and 20 shut-in heavy-oil wells. The deal incorporates production of approximately 37 barrels of oil per day with significant upside from a proposed Cummings multilateral well and workove…

Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals announced promising 52-week Phase 1b/2a RESOLVE trial results for EP-104GI, showing sustained clinical remission and histologic improvements in patients with Eosinophilic Esophagitis (EoE) after a single dose. The treatment demonstrated favorable safety with no serious adverse events, supporting potential for a once-annual …

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Immutep Limited, a late-stage immunotherapy biotech firm, has received approximately A$856,669 from the Australian Federal Government's R&D tax incentive program for its 2025 fiscal year expenditures. The funding, including additional French and German tax incentives, supports the advancement of its cancer and autoimmune disease therapies, notably …

Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States

Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States

Celcuity Inc. announced that its drug REVTORPYK (gedatolisib) is now commercially available in the United States for treatment of hormone receptor-positive, HER2-negative advanced breast cancer patients without PIK3CA mutation, following progression on endocrine therapy. REVTORPYK, a first-in-class inhibitor of all class I PI3K isoforms and mTOR co…

Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment

Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment

Banzai International, Inc. (Parabolic) has executed initiatives following its ConnectAndSell acquisition that are expected to yield approximately $9.3 million in annualized cost savings. These savings come from workforce reductions, minimized third-party contractor use, and the implementation of a new business unit operating model aimed at improvin…

Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview

Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview

Cycurion, Inc. announced its largest contract award to date, a $54.6 million 10-year engagement supporting the modernization of a major state Health and Human Services system. The company also completed the acquisition of Digital Ally's Video Solutions business, expanding its public safety portfolio and recurring revenue base. CEO L. Kevin Kelly em…

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

Verrica Pharmaceuticals announced they will present new analysis from Phase 3 trials indicating their FDA-approved drug YCANTH (VP-102) clears molluscum contagiosum lesions approximately four times faster than vehicle, regardless of disease duration. Additional data on investigational drug VP-315 for skin cancer will also be showcased. The clinical…

Ten-League International Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2026

Ten-League International Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2026

Ten-League International Holdings Limited reported its unaudited financial results for the first six months of fiscal year 2026, showing total revenues of S$33.1 million (US$25.6 million) with a significant shift towards higher-value engineering consultancy services and rental income representing 45.4% of total revenue compared to 18.5% last year. …

Asure Software Accelerates Alabama Investment with U of Alabama HR Management Conference Sponsorship Followed by October 23 Gardendale Open House

Asure Software Accelerates Alabama Investment with U of Alabama HR Management Conference Sponsorship Followed by October 23 Gardendale Open House

Asure Software, a Nasdaq-listed provider of payroll and HR solutions, is accelerating its investment in Alabama by sponsoring The University of Alabama's 72nd Annual Human Resources Management Conference and hosting an open house at its Gardendale hub. Serving over 1,200 Alabama customers and targeting growing Alabama businesses, Asure aims to deep…

Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine

Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine

Theriva Biologics announced peer-reviewed publication in Nature Medicine of its Phase 2b VIRAGE trial results demonstrating that VCN-01 combined with standard chemotherapy improves survival outcomes in metastatic pancreatic cancer patients. The data supports an immune-mediated mechanism of action, and Theriva has initiated a Phase 2a follow-up tria…

Firefly Aerospace Signs Starcloud as Commercial Customer, Demonstrating Data Center Capabilities Around the Moon

Firefly Aerospace Signs Starcloud as Commercial Customer, Demonstrating Data Center Capabilities Around the Moon

Firefly Aerospace has signed Starcloud as a commercial customer to fly an advanced AI computing payload (SC-1L) aboard its Elytra lunar orbital vehicle, aiming to validate data center capabilities around the Moon. The partnership demonstrates the potential for processing and transmitting lunar data directly from orbit, bolstering infrastructure for…

DarkIris Inc. Provides Business Update on Cine3.AI Global Expansion and Entertainment Technology Ecosystem

DarkIris Inc. Provides Business Update on Cine3.AI Global Expansion and Entertainment Technology Ecosystem

DarkIris Inc. provides a business update on the development and global deployment of its AI-powered film production platform, Cine3.AI, positioning for the 'Cinema 3.0' era of AI-integrated content creation. The company has established a U.S. subsidiary to spearhead North American expansion, focusing on commercialization, IP licensing, and AI-enabl…

NCL Corporation Ltd. Announces Proposed Offering of Senior Notes

NCL Corporation Ltd. Announces Proposed Offering of Senior Notes

NCL Corporation Ltd., a subsidiary of Norwegian Cruise Line Holdings Ltd., announced a proposed private offering of $750 million senior notes due 2031. The proceeds will be used to redeem outstanding 2028 senior notes, repay borrowings under their revolving loan facility, and prepay export-credit financed debt. This refinancing aims to optimize the…

Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide

Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide

Rekor Systems announced that the Oregon Department of Transportation intends to award them a $1.4 million contract over five years to implement their Connected In-Vehicle Alerts program statewide. This program will bring timely roadway safety alerts directly to drivers via vehicle displays and navigation apps, building on Rekor's successful deploym…